USPTO serial 79326473
M MENARINI PILLS OF RESEARCH
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 16, 2023
- Examiner
- MCCAULEY, BRENDAN D
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with M MENARINI PILLS OF RESEARCH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l.
IT
Other trademarks owned by A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l.
A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l.
IT
Other trademarks owned by A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l.
A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l.
IT
Other trademarks owned by A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Arthur J. DeBaugh
Arthur J. DeBaugh Allman Spry Leggett Crumpler & Horn, P.A.380 Knollwood Street, Suite 700Winston-Salem, NC 27103United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Antibiotics; anti-cancer preparations; pharmaceutical preparations for the treatment of inflammatory disorders; medicated preparations for skin treatment; pharmaceutical preparations for treating skin disorders | ACTIVE | — |
| 009 | Blank magnetic data carriers; recording discs, namely, blank compact discs, blank audio discs, and blank computer discs; recording discs, namely, audio discs and compact discs featuring information on research and development in the pharmaceutical and biotechnology fields; DVDs featuring information on research and development in the pharmaceutical and biotechnology fields; blank compact discs; digital recording media, namely, pre-recorded video cassettes, digital video discs, digital versatile discs, downloadable audio and video recordings, DVDs, and high definition digital discs featuring information on research and development in the pharmaceutical and biotechnology fields; downloadable computer software for editing cinematographic film and for creating videos; apparatus for editing cinematographic film; electronic downloadable publications, namely, newsletters and magazines in the field of medicine; camcorders; photographic cameras; cinematographic films featuring information on medicine; musical sound recordings; musical video recordings; blank USB flash drives | ACTIVE | — |
| 016 | Paper; paper stationery; printed materials, namely, books, magazines, printed matter in the nature of printed booklets, catalogues, printed publications in the nature of newsletters and brochures and pamphlets in the fields of pharmaceutical drugs, medicine and art; stationery; writing stationery; cardboard boxes; conical paper bags; printed postcards; printed advertising posters; printed mounted posters; printed photographs; placards of paper; placards of cardboard; signboards of paper; printed calendars; printed almanacs; copyholders; paperweights; pencil holders; pens; writing or drawing books; printed diaries | ACTIVE | — |
| 041 | Education services, namely, arranging and conducting of seminars, conferences and conventions in the fields of pharmaceutical drugs, art, and medicine; organization of educational, entertainment, sporting, and cultural events, namely, events in the fields of pharmaceutical drugs, art, and medicine for cultural or educational purposes; digital video, audio, and multimedia publishing services; organization of cultural activities in the fields of pharmaceutical drugs, medicine, and art; production of radio and television entertainment services; audio recording and video production, and photography; production of television programs | ACTIVE | — |
| 042 | Pharmaceutical research services; scientific research; genetic research; medical research; biological research; biotechnology research; laboratory research services relating to pharmaceuticals; research services relating to pharmaceuticals; scientific research services; biomedical research services; bacteriological research and analysis; stem cell research services; research and development of vaccines and medicines; research and development in the pharmaceutical and biotechnology fields | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l.
- Other trademarks owned by A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l.
- Other trademarks owned by A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l.
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 016
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named M MENARINI PILLS OF RESEARCH
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 2, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 2, 2026 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Aug 2, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 2, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 3, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 18, 2023 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Aug 18, 2023 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Aug 16, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 16, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 16, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 28, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 28, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 27, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 8, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 8, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 8, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 25, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 25, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 25, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 25, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 25, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 24, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 24, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 24, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 25, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 25, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 25, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 27, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 25, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 25, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 2, 2022 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Apr 28, 2022 | CREV | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | — |
| Mar 20, 2022 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Feb 6, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 11, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 10, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 16, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 15, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 14, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 13, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 8, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 7, 2021 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Nov 25, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |